Publications & Resources

How Hospitals Can Support Healthcare Worker Mental Health

MLMIC shares strategies to alleviate the stress of physicians and other clinical staff amid the ongoing challenges of COVID-19.

How Physicians Can Support Patients with Long COVID-19

Prioritizing empathy, setting care goals and involving multi-disciplinary specialists may help physicians address post-COVID conditions.

Encouraging Patients to Resume Routine Care

MLMIC shares tips to help physicians encourage patients to return to routine care after delays caused by COVID-19.

The Consequences of Delays in Surgeries and Preventive Screenings Due to COVID-19

Delays in preventive screening exams can exacerbate diseases and conditions such as diabetes, heart disease, and cancer if they go undiagnosed, unmonitored, and untreated.

Update on Elective Surgeries in New York State

Amid another surge in COVID-19 cases, a New York State executive order requires hospitals or health systems with limited capacity to limit non-essential elective procedures.

The Crisis of Physician Burnout During COVID-19

While caring for patients throughout the global healthcare crisis, physicians have put themselves at risk of contracting COVID-19 and dealt with a lack of resources and staff – all while taking care of, or in many cases, neglecting, their own mental health.

Experts Caution Against Opioid Issuance for Long-COVID

A troubling percentage of long-COVID patients are using opioids to address the scope of symptoms that can cripple one’s health for months after a diagnosis.

How to Address Pandemic-Related Patient Safety Threats

The Agency for Healthcare Research and Quality Patient Safety Network’s annual perspective summarizes COVID-19’s impact on patient safety and strategies for addressing these evolving challenges.

Assessing Patient Readiness for Elective Surgery Following COVID-19

Guidance published by Oregon Health & Science University scientists outlines a preoperative protocol for surgical care teams to evaluate the readiness of previously COVID-positive patients for elective procedures.

FDA Issues Alert on SARS-CoV-2 Viral Mutations and the Associated Impact on Testing

The U.S. Food and Drug Administration is evaluating the potential impact of SARS-CoV-2 viral mutations on authorized molecular tests.